Jack D. Bui

Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers

Ayuko Hoshino, Han Sang Kim, Linda Bojmar et al. · Cell · 2020 · 1.2K citations · Full text

Medicine, Cancer Biology, Oncology +12

A critical function for type I interferons in cancer immunoediting

Gavin P. Dunn, Allen T. Bruce, Kathleen C. F. Sheehan et al. · Nature Immunology · 2005 · 597 citations

Medicine, Immunology, Oncology +14

PD-L1:CD80 Cis-Heterodimer Triggers the Co-stimulatory Receptor CD28 While Repressing the Inhibitory PD-1 and CTLA-4 Pathways

Yunlong Zhao, Calvin K. Lee, Chia‐Hao Lin et al. · Immunity · 2019 · 391 citations · Full text

Life Sciences, Immunology, Molecular Biology +17

Cancer immunoediting by the innate immune system in the absence of adaptive immunity

Timothy E. O’Sullivan, Robert Saddawi‐Konefka, William Vermi et al. · The Journal of Experimental Medicine · 2012 · 331 citations · Full text

Life Sciences, Immunology, Oncology +17

Intratumoral immunotherapy using platelet-cloaked nanoparticles enhances antitumor immunity in solid tumors

Baharak Bahmani, Hua Gong, Brian T. Luk et al. · Nature Communications · 2021 · 297 citations · Full text

Life Sciences, Immunology, Oncology +17